We aim to provide you with timely and comprehensive biotech news and updates from China. This includes information on Investigational New Drug (IND) applications, New Drug Applications (NDAs), and the latest clinical trials. We strive to be your primary source of reliable and valuable information.
Email: info@cnbio.xyz
Comments